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Summal~ 
5E6 is a cell surface molecule expressed on a subpopulation of murine natural killer (NK) cells 
that  are involved in  the  specific  rejection of H-2  a or  H-2  f (hemopoietic histocompatibility 
determinant 2) bone marrow cell grafts. Here, we isolated and cloned the gene encoding 5E6 
and determined the nucleotide sequence of the eDNA. 5E6 is nearly identical to Ly-49C;  the 
deduced amino acid sequence reveals a polypeptide of 266 amino acids with a molecular weight 
of 31,284 that contains multiple cysteine residues to explain its disulfide-linked homodimer structure 
and five potential N-linked glycosylation sites. 5E6 is a type II integral membrane protein with 
an  extracellular carbohydrate recognition domain characteristic of C-type  (Ca2+-dependent) 
animal lectins. Chromosomal mapping indicates that 5E6 is located within the NK gene complex 
on chromosome 6. The sequence of 5E6 mRNA and the degree of glycosylation of 5E6 protein 
are under genetic control. Immunoprecipitation before removal of N-linked sugars reveals different 
size molecules. There are several nucleotide differences among BALB/c, B6, and NZB mRNAs; 
however, none of them would be expected to affect N-glycosylation. Of particular interest are 
two findings: (a) BALB/c, B6, and (BALB/c  x  B6)F1 5E6 reduced molecules are m65, 54, and 
54 kD, and (b) the eDNA sequence of (BALB/c  x  B6)F1 is identical to B6. Thus, there appears 
to be allelic exclusion of 5E6 expression that may be related to the ability of F1 hybrid mice 
to reject parental H-2  a bone marrow cell grafts. 
N 
'K cells comprise a small population of lymphocytes that 
have a large granular morphology and are distinct from 
mature T  and B cells and from cells of the myeloid lineage 
(1, 2). NK cells are defined as a functionally important im- 
mune effector population that display "natural" cytolytic ac- 
tivity against certain tumor cells and vitally infected cells in 
a manner that is not MHC restricted (3, 4).  NK cells also 
mediate the rejection of incompatible bone marrow cell al- 
lografts in lethally irradiated mice, possibly by the specific 
recognition of recessively inherited hematopoietic histocom- 
patibility i  (Hh-1)1 antigens, a phenomenon known as "hy- 
brid resistance" (5-7).  The mechanism by which NK cells 
1 Abbreviations used in this paper: A-LAK, adherent  lymphokine-activated 
killer (cells);  DGGE, denaturing  gradient gel electrophoresis;  Hh-1, hema- 
topoietic histocompatibility  1; RI, recombinant  inbred; UT, untranslated. 
recognize bone marrow cells in a highly specifc manner and 
mediate hybrid resistance is not known. However, it has been 
postulated that  specific receptors are present on subsets of 
NK cells that allow for this recognition. Indeed, NK-specific 
molecules have been reported in humans (8-12), rats (13, 14), 
and mice (15-22). 
Recently, several murine NK cell receptor-like molecules 
have been cloned and categorized into two genetically linked 
families termed the NKR-P1 and Ly-49 gene families. These 
gene families share some structural features and are located 
in close proximity on mouse chromosome 6 in an area that 
has been termed the NK gene complex (23, 24). These two 
families of molecules have been suggested to deliver opposing 
signals, with NKR-P1 molecules activating natural killer and 
Ly-49 molecules delivering inhibitory signals to NK cells when 
they encounter certain MHC class I molecules on target cells 
(23,  25). 
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lation of '~50% of murine NK cells of most strains tested. 
Previous experiments in this laboratory have shown that treat- 
ment  of recipient mice with mAb SW5E6  eliminates the 
ability to reject H-2  d but not H-2  b bone marrow cell grafts 
(26, 27). In this study, we report the cloning, chromosomal 
mapping, and molecular characteristics of the 5E6 gene, as 
well as its unique expression in different strains of mice. 
Materials  and Methods 
Cell Purification and Cell Culture.  Murine cells were cultured 
in RPMI 1640 (GIBCO BRL, Gaithersburg, MD) supplemented 
with 10% FCS (Hyclone Laboratories, Logan, UT), 2 mM t-gluta- 
mine, 100 U/ml penicillin, 100/~g/ml streptomycin  (Irvine Scientific, 
Santa Ana, CA),  1 mM sodium pyruvate, and 0.1 mM nonessen- 
tial amino acids (GIBCO BRL) (complete RPMI). COS-7 cells 
have been described (28) and were cultured in DMEM (GIBCO 
BRL) with the same supplements (complete DMEM).  Adherent 
lymphokine-activated killer (A-LAK) cells were prepared as previ- 
ously described (29) with minor modifications.  Briefly,  A-LAK cells 
were generated by culturing nylon wool nonadherent spleen cells 
in T25 flasks (Corning Inc., Coming, NY) in RPMI 1640 com- 
plete media (RPMI 1640 [GIBCO BILL] supplemented with 10% 
FCS [Hyclone Laboratories], 2 mM L-glutamine, 100 U/ml peni- 
cillin, 100/~g/ml  streptomycin [Irvine Scientific], 1 mM sodium 
pyruvate, and 0.1 mM nonessential amino acids [GIBCO BRL]) 
containing 22.5/~M B-mercaptoethanol (Sigma Immunochemicals, 
St. Louis, MO), 1/~g/ml indomethacin (Sigma), 50/~g/ml gen- 
tamicin (GIBCO BRL), and 500 or 1,000 U/ml human rlL-2 (a 
kind gift from the Cetus Corporation,  Emeryville, CA) (LAK cul- 
turing media) for 3 d at 37~  and 5% CO2. On day 3 of culture, 
the nonadherent cells were removed by gentle washing with warm 
complete RPMI. The adherent cells were further cultured and fed 
every 2-3 d with LAK culturing media, maintaining Ib2 at a con- 
centration  of 500 or 1,000 U/ml. Cells were harvested at 8-9 d 
of  culture. LAK cells from C.B-17 scid/scid bone marrow were pre- 
pared in the same manner, with the exception of the unnecessary 
step of removing the nonadherent  T cells on day 3. 
Construction ofcDNA Library.  Total cytoplasmic  RNA was pre- 
pared from day 9 C.B-17 scid/scid LAK cells by the acid-gnanidine- 
phenol-chloroform method (30). Poly (A) + RNA was prepared by 
oligo (dT)-cellulose chromatography  using an mRNA separator 
system (Clontech,  Palo Alto, CA) as instructed  by the manufac- 
turer.  The cDNA library was constructed  using  the superscript 
system for cDNA synthesis and cloning (BILL-Life  Technologies, 
Inc., Gaithersburg, MD). Briefly, first-strand cDNA was synthe- 
sized from 5 #g of poly (A) + RNA using a modified Moloney 
murine leukemia virus (M-MLV) reverse transcriptase, Superscript 
RT, (GIBCO BRL) and a NotI primer adapter 5'-pGACTAGTT- 
CTAGATCGCGAGCGGCCGCCC(T)1s-3',  which provided direc- 
tionality to the cDNA. Second-strand synthesis was by nick trans- 
lational replacement of the mRNA, as first described by Okayama 
and Berg (31). SalI adapters were ligated to the 5' end of the cDNA 
followed by digestion with NotI to yield cDNA with 5' SalI and 
3' NotI ends. The cDNA was then size-fractionated by passage 
over a Sephacryl S-500 HR column. The resulting cDNA was then 
ligated to XhoI-NotI-digested pME18S vector (kindly provided 
by Dr. Kevin Moore, DNAX Research Institute, Palo Alto, CA). 
The pME18S vector is a powerful mammalian expression vector 
containing the SRo~ promoter (composed of the SV-40 early pro- 
motet along with the R  segment and part  of the U5 sequence 
(R-U5') of the long terminal repeat of  human T cell leukemia virus 
I (32), the SV-40 small t intron, the SV-40  poly(A) and splice  signals, 
as well as the pUC 18 origin and the ampicillin-resistance gene. 
The ligated cDNA was introduced into MC1061 bacteria by elec- 
troporation. Approximately 2  x  107 independent clones were ob- 
tained with an average  size ofl.6 kb and a range of  0.8 to >3.5 kb. 
Isolation and Characterization of cDNA Clone.  The cDNA library 
was screened by multiple rounds of transient expression in COS-7 
cells and immunoselection by panning  as described by Seed and 
Aruffo (33). In the first round, COS-7 cells were transfected by 
the DEAE-dextran method (34). Selection was by panning with 
sheep anti-mouse IgG (Jackson ImmunoResearch  Laboratories,  Inc., 
West Grove, PA)-coated plates and mAb SW5E6. Episomal DNA 
was recovered by the method of Hirt (35) and used to transform 
Escherichia coli MC1061 by electroporation.  The bacteria were 
amplified in liquid media and the plasmid DNA was reintroduced 
into COS-7 cells by spheroplast fusion according to the method 
of Sandri-Goldin et al. (36). After one additional round of sphero- 
plast fusion, panning, recovery ofplasmid DNA, and transforma- 
tion, the bacteria were plated so as to obtain individual colonies. 
Plasmid DNA was prepared from 18 individual colonies and used 
to transfect COS-7 cells by the DEAE-dextran method, and 48 h 
later the cells were recovered, stained with mAb SWSE6, and ana- 
lyzed by flow cytometry  using a FACScan  |  flow cytometer.(Becton 
Dickinson & Co., Mountain View, CA). Three of the clones showed 
positive staining for 5E6 and had inserts of '~1.3 kb. Each of the 
clones were subcloned into the multifunctional vector Gemscript 
(a gift from David Crawford,  University of Texas Southwestern 
Medical Center, Dallas, TX). The largest of  these clones, p5E6GS.16, 
was used to prepare' a set of nested deletions from each end of the 
cDNA using  exonuclease III  (37). Clones  that  were "~150 bp 
different in size were isolated and used for sequence analysis by 
the dideoxynucleotide chain termination  method (38) using the 
Sequenase system (United  States Biochemical Corp.,  Cleveland, 
OH). The clone was sequenced completely on both strands. Se- 
quence analysis and database comparison were performed using the 
Genetics Computer Group, Inc. (Madison, WI) suite of  programs. 
Reverse Transcription  PCR Amplification of  5E6 eDNA from D~'fferent 
Mouse  Strains.  Poly(A)  + RNA was isolated from NK cells of 
C57BL/6, BALB/c, BALB.B, CB6F1, and NZB by using the Fast 
Track mRNA isolation kit (InVitrogen, San Diego,  CA).  First- 
strand cDNA was  synthesized from 1 #g of poly (A) + RNA 
using the modified reverse transcriptase, superscript RT (GIBCO 
BRL), and a random primer. A 1.1-kb fragment of 5E6 that con- 
tains the complete coding region, as well as 145 bp 5' untranslated 
(UT) and 157 bp 3' UT sequences, was amplified using the fol- 
lowing two primers: 5E6-20(5'-ATCATGAGGTTGAGTATCACC-Y) 
and 3' primer, 5E6-1D2 (5'-GCAAAGCGTGCCCATTCAC-3'). 
The PCR mixture contained 1/~M of  each primer, 200/~M dNTPs, 
1 x PCR buffer, 1 U Ampli Taq DNA polymerase, 5 #I ofcDNA 
reaction product and 2 mM magnesium chloride in a reaction volume 
of 50 #1. PCR conditions were 94~  4 min, 35 cycles of 94~ 
1 min, 55~  1 min, 72~  1 min followed by extension of 72~ 
for 7 rain. 5 #1 of the PCR products were run on 1.2% agarose 
gel and visualized by staining with ethidium bromide. A portion 
of the product (1/~1) was used for TA cloning according to the 
instructions provided  by the supplier (InVitrogen). The cloned genes 
were sequenced by using specific primers based on the sequence 
of 5E6 from BALB/c using  the Sequenase system. 
Surface Iodination, Immunoprecipitation, Removal of N-linked Car- 
bohydrates, and SDS-PAGE.  Transiently transfected COS-7 cells 
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Na12SI (Amersham Corp.,  Arlington  Heights,  IL)  using  lac- 
toperoxidase as described (39). Cells were washed three times in 
PBS and lysed in 50 mM Tris, pH 8.0, 1% NP-40 (Sigma) con- 
taining 1 mM EDTA, 0.5/zM leupeptin, 0.7/zM pepstatin, and 
150  /zg/ml  PMSF (Boehringer Mannheim  Biochemicals, Indi- 
anapolis, IN) for 10 rain on ice. The nuclei were removed by cen- 
trifugation at 12,000 g for 10 min. The lysates  were precleared  with 
rabbit anti-mouse  IgG (Jackson ImmunoResearch Laboratories) 
coated protein A-Sepharose (Pharmacia  Fine Chemicals, Piscataway, 
NJ) for 30 rain at 4~  while rocking. Predeared lysates were in- 
cubated with mAb SWSE6 or isotype control mAb 22B5 for 2 h 
at 4~  while rocking. Protein A-Sepharose coated with rabbit 
anti-mouse IgG was added for an additional 45 rain at 4~  while 
rocking. The beads were recovered by centrifugation and washed 
three times with NET gel (50 mM Tris-HC1, pH 7.5, 150 mM 
NaC1, 0.1% NP-40, 1 mM EDTA, 0.25% gelatin, 0.02% sodium 
azide). The bound proteins were eluted by boiling for 5 min in 
SDS sample buffer for SDS-PAGE analysis or in antigen elution 
buffer (100 mM Tris-HC1, pH 7.5, 1% SDS, 1%/3-mercaptoethanol) 
for removal of N-linked carbohydrates. Endoglycosidase  F diges- 
tion was performed by removing the supernatant from the beads 
and adding endoglycosidase  F buffer (0.1 M potassium phosphate, 
pH 6.1, 1% Triton X-100, 0.1% SDS, 45 mM EDTA, 1% B-mer- 
captoethanol) to a final volume of 1 ml. 1 U of endoglycosidase 
F/N-glycosidase  F (Boehringer  Mannheim Biochemicals)  was added 
and the samples were allowed to digest overnight at 37~  The 
protein was precipitated with TCA and washed three times with 
ice cold acetone followed by addition of I  x  SDS sample buffer 
and boiling for 5 rain. Samples were analyzed on 12 or 7.5% slab 
gels according to the method of Laemmli (40). Gels were fixed, 
dried, and exposed to Hyperfilm-MP  (Amersham  Corp.) at -70~ 
Genetic Mapping of 5E6(Ly-49C).  Mapping of 5E6(Ly-49C) was 
performed using a panel of 26 genomic DNAs representing the 
complete C57BL/6  x DBA/2 (B x D) recombinant inbred strain 
collection. Candidate primer sequences for the amplification of 
genomic fragments from 5E6(Ly-49C) were initially  identified  using 
the computer program Primer (kindly provided by Eric Lander, 
Massachusetts Institute of Technology, Cambridge, MA) to ana- 
lyze the cDNA sequence of 5E6(Ly-49C). The primer sequences 
ultimately selected were: 5' TTCCCTGATTAATTTTCCAACC 
and 3' TCTTTCTTGTGTTAAGACTTCCG.  These sequences  were 
from the 3' end of 5E6(Ly-49C) and amplified a 278-bp genomic 
fragment that had minimal homology with sequences in Ly-49. 
Polymorphisms between C57BL/6 and DBA/2 in this amplified 
fragment were identified by automated nucleotide sequence anal- 
ysis using an automated DNA sequencer (model 373; Applied Bio- 
systems, Inc., Foster City, CA) as previously  described (41). Allelic 
forms of the amplified fragment were subsequently distinguished 
by denaturing gradient gel electrophoresis (DGGE) as previously 
described (42). Preliminary analysis  using perpendicular gradients 
established that optimal variation in DGGE mobility occurred in 
a denaturing  gradient of 30-70%  for 5E6(Ly-49C) alleles from 
C57BL/6 and DBA/2.  The genotypes of all 26 B  x  D recom- 
binants strains were determined for 5E6(Ly-49C) by standard ana- 
lytical techniques (43) as described previously (44) using the MAP 
MANAGER software package and database (kindly provided by 
K. Manly, Roswell Park Cancer Institute,  Buffalo, NY). 
Chromosomal Mapping by PCR Analysis of Somatic Cell Hybrid 
DNA.  Based  on the 5E6 cDNA sequence, primers were designed 
to specifically  amplify  a 3' portion of the 5E6 gene. The sense  primer 
corresponds to nucleotides 925-947 (5' ATTCCCTACTACTGT- 
ATTTGTGG 3') and the antisense primer corresponds to nucleo- 
tides 1,134-1,116 (5' GCAAAGCGTGCCCATTCAC 3'). A PCR 
mixture of 0.5/zM primers, 200/~M dNTPs, and 1￿  Amersham 
Hot Tub buffer, plus an Ampliwax "gem" (Perkin Elmer Corp., 
Norwalk, CT) was put through a "hot start" of 75~  for 15 min 
followed by cooling to 20~  DNA (100 rig) and Amersham Hot 
Tub Taq polymerase  (1.25 U) were then added to each  reaction mix. 
PCR conditions were 94~  5 min, 35 cycles: 94~  1 min, 62~ 
1 min, and 72~  I min, followed by extension at 72~  for 7 min 
and storage at 4~  A portion of the PCR product (9 #1 of the 
50/zl total) of each sample was electrophoresed on a 2% agarose 
gel and visualized by staining with ethidium bromide. 
Results 
Isolation and Characterization of 5E6 cDNA Clon~  A cDNA 
library was constructed in the mammalian expression vector 
pME18S using mRNA isolated from IL-2-propagated C.B- 
17 (scid/scid) bone marrow cells. The library was transfected 
into COS-7 cells and these cells were then screened for sur- 
face  expression  of the  5E6  molecule using  the  transient 
expression-immunoselection procedure of Seed and Aruffo 
(33). After three rounds of transfection and selection by pan- 
ning using the mAb SW5E6, 18 bacterial colonies were iso- 
lated at random for further analysis. Three of these plasmids 
contained inserts of "~  1.2 kb and each of these clones directed 
the surface expression  of 5E6 protein on transfected COS-7 
cells as determined by staining with the 5E6 mAb and flow 
cytometry analysis (Fig.  1). Each of these three clones were 
identical at the 3' end and differed only in the length of the 
5' untranslated region. The nucleotide sequence of the largest 
clone is shown in Fig. 2. Comparison of the predicted amino 
acid sequence of 5E6 to the databanks revealed 64% identity 
to the Ly-49A molecule (75% identity at the nucleotide level) 
(data not shown). The 5E6 polypeptide also contains an ex- 
tracellular carbohydrate recognition domain characteristic of 
Ca2+-dependent  lectins (45) and members of the Ly-49 gene 
family (23,  24).  Comparison of the carbohydrate recogni- 
tion domains of 5E6 and several other known C-type lectins 
shows that multiple residues  are conserved and that 5E6 is 
a member of this group of molecules. The 5E6 cDNA was 
found to be identical to a previously reported molecule, Ly- 
49C (17), with the following exceptions.  The 5E6 cDNA 
is 84 nucleotides longer at the 5' UT sequence and has a 78-bp 
deletion at nucleotide 995 in the 3' untranslated region cor- 
responding to nucleotides 912-989  of the reported Ly-49C 
sequence.  There are also two nucleotide differences  at 279 
and 280. We report a cytosine followed by an adenine, while 
Ly-49C is reported to have an adenine followed by a thymi- 
dine.  This results in a change from asparagine  in the 5E6 
peptide to tyrosine in the Ly-49C peptide (data not shown). 
Comparison of amino acid sequence  of 5E6 from different 
strains  of mice is shown in Fig.  3. 
The 5E6 cDNA Reveals Significant Polymorphism.  Southern 
blots of HindlII-, BamHI-, and EcoRI-digested DNA from 
307  Stoneman  et al. Figure  1.  Cell  surface  expression  of 5E6  on  transiently  transfected  COS-7  cells.  COS-7  cells were  stained  with  biotin-conjugated  anti-5E6  mAb 
followed by PE-conjugated  streptavidin (filled histograms)  or with secondary reagent only (streptavidin-PE) (open histograms).  Analysis was on a FACScan  | 
flow cytometer.  (.4)  Untransfected  COS-7  cells.  (B) COS-7  cells transfected  with pME18S  vector  only.  (C)  COS-7  cells transfected with  5E6 cDNA 
clone  number  16.  The  two  other  positive  cDNA  clones  showed  similar  staining  patterns. 
NZB, C3H, 129/J, DBA/2, BALB/c, and C57BL/6 liver hy- 
bridized to the full-length  5E6 cDNA revealed the presence 
of multiple  bands (data not shown). Previous reports have 
shown that the closely  related gene,  Ly-49A,  divides most 
common laboratory mouse strains into five polymorphic pat- 
terns (46). Our limited analysis shows that the 5E6 gene cor- 
responds to the same pattern, with BALB/c, C3H, and DBA/2 
having  identical  RFLP patterns and C57BL/6,  NZB,  and 
129/J each having unique RFLP patterns. These results are 
consistent with the hypothesis that there are multiple members 
of the Ly-49 gene family, and indeed, several new molecules 
have recently been identified that have significant homology 
to Ly-49A  (47). 
The 5E6 Gene Maps to the NK Complex on Mouse Chromo- 
some 6.  PCR analysis using  primers specific for 5E6 was 
performed using DNA from a panel of mouse-hamster  so- 
matic cell hybrids (48). Genetic marker analysis revealed that 
each hybrid had randomly segregated mouse chromosomes 
and that the panel as a whole was informative for assigning 
genes  to any mouse chromosome  (49).  Products were ob- 
tained from the parental mouse cell DNA and from only those 
hybrids containing mouse chromosome  6 (data not shown). 
The  percent  discordancy  for  each chromosome  using  17 
different hybrid cell lines indicated that chromosome  6 had 
a 0% discordancy. These results place the 5E6 gene on chro- 
mosome 6 with a high degree of probability. Independently, 
the chromosomal  location  of 5E6(Ly-49C) was determined 
using the B  x  D recombinant inbred strain panel. Polymor- 
phisms distinguishing  the 5E6(Ly-49C) alleles present in the 
C57BL/6  and DBA/2 parental strains were sought in  the 
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TGA~GAGGAGGGG~AGA~AAT~ATGAGGTTGAGTATCACCCGGTGGAAATTTAGTTCCGT~TTT~TTTTGAAACTCGTAGGAGATCTA 
~CCAGAAAA~GCC~GTTTCAGA~AAATTTT~C~TCcA~CAG~AT~ACTCCGGTAGAGACACAGACTT~TTGTACT~C~GATGAGT 
MS 
GAG~CAGAGGT~A~TTA~TC~TGTGAGA~TT~AT~GTCTTCAGGGTTGCAGAAAC~GT~GGCATGAGGAGACTC~GGG~c~AGA 
EPE  TY  TVR  HK  SG  QKQVRH  ET  GPR 
G~GTTGG~CAGAAAGTGTT~AGCA~C~TGG~CT~ATTGTGAAAGCTCTTGG~TCCTCTGTTTCCTTCTTcTTGT~CAGTTGCA 
EVG  RK~SAP  QL  VK  LGIL~F  L~  T~ 
GTGTTGGCAGTAAAGATTTTTCAGTAT~TC~CACAAAC~GAAATC~TGAAACTCTAAACCATCACCAT~CTGCAGC~CATGC~ 
V~A  KI  QYNQHK  EI~LNHHHNm  NMQ 
AGTGATTTC~CTTAAAGG~AAATGTTGACAAAT~GTCTATAGATTGTAGGCC~GC~TGAAA~TCTGG~TATATCAAAAGAG~ 
SDF  LK  EML  NK  ID  RPSNE~LEY  KRE 
CAGGACAGATGGGACAGTAA~CAAA~ACTGTTTTAGATTCCTCACGGGACACAGGCAGAGGTGTTAAATACTGGTTCTGCTATAGTACT 
QDR  DS  TKT  LD  SR  TGRGVK  WF  YST 
/~ATGTTATTATTTCATCATG~CA~CTACATGGAGTGGATGTAAAGCG~CTGCCAGCATTTTAGCGTTCCCATTCTG~GATAG~ 
K  B  Y  F  ~  N  K  T  w  s  w  K  ~  ~  e  H  ~  S  V  P  ~  K  ~  E 
GATG~GATG~CTG/ZAATTCCTTC~CGCCATGTTATTCCAGAG~TTACTGGATTGGATTGTCTTATGAT~GA~GG~TGG 
DED  LK  LQR  VI  EN  WIGLSYDKK  KEW 
GCATGGATTGAC~TGGCCCATCT/~CTTGACATG~AAT~GG~u~AATG~CTTT~GTCTAGAGGATGTGTATTTTTATCTAAAGCA 
AWl  NG  SKLDMK  RK  NFKSRG~VF  S  K  A 
AG~TAG~GATATTGACTGT~TATTCCCTACTA~TGTATTTGTGGG~GAAACTGGAT/~ATTC~CTGATT~TTTTCC~CCAGAGT 
R!E  ID  NIP  Y~  ~G  KLDKFP 
TAAAG~CATAGTCTCCTGTG~GAGAAACAAAGCTGC~G~CATTGGGACTGTACTCTCCTATCTATCTTGACAG~CAGAGGTCATT 
TTCTATCCTGTTGGAGAGAGGACGCATCTACTCGGGTG~TGGGCACGCTTTGCCCTAAAGCCTTCAG~TTGTGTTCTTTCTGATTTcT 
TAAACTCCCATAAAACTGAATAAAGAGTCCTCCCT 
2 
32 
62 
92 
122 
152 
182 
212 
242 
266 
Figure  2.  Nucleotide sequence of the 5E6 cDNA in- 
sert and predicted amino acid sequence of the 5E6 pep- 
tide. The predicted transmembrane region is double un- 
derlined.  Five potential N-linked glycosylation sites are 
underlined.  The polyadenylation signal is in bold letters 
and underlined.  The nucleotide  sequence  is numbered 
on  the  left  side  and  the  amino  acid  sequence  is num- 
bered on the right side Cysteine residues  are highlighted. 
These sequence data are available from GenBank under 
accession  number  U09739. 
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Figure 3.  Comparison  of amino acid  sequences  of 5E6 from different 
strains of mice. The amino acid  residues different  from BALB/c  only are 
shown. The potential N-linked glycosylation  sites (Asn-X-Thr/Ser) are 
boxed. 
3' region of 5E6(Ly-49C), since this portion of 5E6(Ly-49C) 
is highly divergent from the sequences of other members of 
the Ly-49 family. Several primer pairs were evaluated initially, 
leading to the identification of a set of primers that amplified 
a fragment spanning a previously unidentified 78-bp  intron 
positioned at nucleotide 995 in the cDNA sequence of  5E6(Ly- 
49C). The primer sequences  used to amplify the region of 
5E6(Ly-49C) surrounding  this  intron  (see Materials  and 
Methods) are not present in other members of the Ly-49 family, 
thus providing an assay specific for variations in 5E6(Ly-49C). 
Sequence  comparisons  of the  278-bp  genomic  fragment 
amplified from C57BL/6 and DBA/2 revealed allelic varia- 
tions at seven nucleotide positions in the intron and exon 
sequences  of this fragment (data not shown). These allelic 
sequence variations resulted in a readily detectable variation 
in mobility  in denaturing gradient gel electrophoresis (DGGE), 
and this assay was used to determine the 5E6(Ly-49C) geno- 
types of all 26  (B  x  D)  recombinant inbred (RI)  strains. 
The strain distribution pattern obtained for 5E6(Ly-49C) 
was identical to that reported for Ly-49A, Prp, and Ly-55 
for 25 of the 26 ILl strains,  thus mapping 5E6(Ly-49C) to 
chromosome 6 in close proximity to Ly-49A and Ly-55. Rep- 
resentative results of the DGGE assay for 5E6(Ly-49C) poly- 
morphisms between C57BL/6 and DBA/2 are illustrated in 
Fig. 4 A, which also presents the typing results for the single 
RI strain defining recombination between 5E6(Ly-49C) and 
Ly-49A (B  x  D  No.  22).  B  x  D  No.  22 was previously 
reported to carry C57BL/6-derived alleles of Ly-49A (46). 
Our results with 5E6(Ly-49C) typing clearly indicate that 
B  x  D No. 22 carries a DBA/2oderived allele. This DGGE 
typing result for B  x  D No. 22 was confirmed by nucleotide 
sequence  analysis  (data not shown). 
These results position 5E6(Ly-49C)  within the current com- 
posite map for chromosome 6 as illustrated in Fig. 4 B. The 
loci listed on the left are the six reference loci for chromo- 
some 6 defined in the current Chromosome 6 Committee 
Report (50). The (B  x  D) strain distribution pattern (SDP) 
for 5E6(Ly-49C) places it in close proximity with Ly-49A, 
Ly-55, and Prp, all of which have identical SPDs in the cur- 
rent reference data set for the (B  x  D) ILl strains.  Since Ly- 
55 and Ly-49A are placed 2 cM telomeric to Prp, in the cur- 
rent composite map of chromosome 6, this would tentatively 
place 5E6(Ly-49C) telomeric to Ly-55 and Ly-49A. 
Analysis of  the 5E6 Protein in Different  Strains  of  Mice.  The 
mAb SW5E6 has previously been shown to detect an ap- 
parent disulfide linked homodimer with "~54-kD subunits 
on the surface of C57BL/6 and NZB NK cells (26). In this 
study, initial immunoprecipitations using anti-5E6 antibody 
revealed that on BALB/c NK cells 5E6 is present as a homo- 
dimer with '~,65 kD  subunits, while on transiently trans- 
fected COS-7 cells, 5E6 appears as a homodimer with '-54 
kD subunits, as was seen in previous studies with C57BL/6 
NK cells (Fig.  5).  When N-linked carbohydrates were re- 
moved, both species appeared as ~31-kD proteins, indicating 
that the molecular weight difference can be attributed to a 
Figure 4.  (.4)  Representative  data  for the 
genetic typing of 5E6(Ly-49C)  in the BXD 
RI strain panel  using  DGGE. The region  of 
the denaturant  gradient  included  within the 
area of the gel displayed  is shown  at the top 
and the genomic origins of the fragments 
electrophoresed are shown on the left. (B) 
Representation of the genetic map of chro- 
mosome 6 showing  the location  of 5E6(Ly- 
49C). Loci  listed  on the left  are reference  loci 
for chromosome 6 (50), with their interval 
distances in cM. An expanded view of the 
region containing  5E6(Ly-49C)  is shown  on 
the right. All distances  between  loci in cM 
are from  the current  composite  map for chro- 
mosome 6 (50). 
309  Stoneman  et al. Figure 5.  Immunoprecipitation  of the 5E6 antigen synthesized by 
BALB/c A-LAK  cells  and transiently  transfected  COS-7 cells. Cell surface 
proteins were labeled with 12sI, immunoprecipitated,  and electrophoresed 
in 12% SDS-PAGE  under  reducing  conditions  (left panel) or in 7.5% SDS- 
PAGE under  non-reducing  conditions  (right  panel), as described  in Materials 
and Methods. (Lefipanel)  Reducing  gal. Lanes  I-3,  Immunoprecipitates 
from  BALB/c  A-LAK  cell  lysates;  lanes 4-6, immunoprecipitates  from  5E6- 
transfected  COS-7 lysates;  lanes 7 and 8, immunoprecipitates  from  pME18S 
vector  transfected  COS-7  cell  lysates.  (Right panel) Nonreducing  gel. Lanes 
1 and 2, Immunoprecipitates  from BALB/c  A-LAK  cell lysates; lanes 3 
and 4, immunoprecipitates  from 5E6-transfected  COS-7 cell  lysates,  mAbs 
used for each immunoprecipitate  are indicated below each lane and are 
as follows:  control, isotype-matched  irrelevant  antibody  2285; SW5E6, mAb 
anti-5E6. Digestion  with endoglycosidase-F  is indicated  by a + above  rele- 
vant lanes. Positions  of protein molecular  mass markers (in kilodaltons) 
are indicated at the left of each panel. 
Figure 6.  Immunoprecipitation  of the 5E6 antigen synthesized by 
C57BL/6  and BALB/c  A-LAK cells. Cell surface proteins were labeled 
with 12si, immunoprecipitated,  and electrophoresed  in 12% SDS-PAGE 
under reducing conditions  (left panel) or in 7.5% SDS-PAGE  under non- 
reducing conditions (right panel). (Left panel) Reducing  gel. Lanes I and 
2, Immunoprecipitates  obtained  with the isotype-matched,  irrelevant  control 
monoclonal antibody  2285; lanes 3 and 4, immunoprecipitates  obtained 
with anti-5E6  mAb; lanes  5 and 6, immunoprecipitates  obtained  with anti- 
5E6 mAb and digested  with endoglycosidase  E (Right panel) Nonreducing 
gel. Lanes 1 and 2, Immunoprecipitates  obtained  with mAb 2285; lanes 
3 and 4, immunoprecipitates  obtained with mAb SW5E6. Positions of 
protein molecular  mass markers (in kilodaltons) are indicated at the left 
of each pand. 
difference in glycosylation. When 5E6 antigen precipitated 
from BALB/c  (H-2  a) and C57BL/6 (H-2  b) NK cell extracts 
were compared, it was discovered that a difference in molec- 
ular mass indeed exists between these two strains with BALB/c 
having  "~65-kD  subunits  and  C57BL/6  having  ~54 kD 
subunits (Fig.  6).  This difference can also be attributed to 
glycosylation since both appear as  '~31-kD proteins upon 
removal of N-linked carbohydrates. We also compared 5E6 
immunoprecipitates from BALB.B (H-2  b on BALB/c back- 
ground) and BALB/c  x  C57BL/6 (CB6F1), and it was ob- 
served that the 5E6 protein on CB6F1 NK cells exists as the 
smaller form ("~54  kD),  while on BALB.B NK cells,  5E6 
is an intermediate size  of "~60  kD  (Fig.  7).  To determine 
whether the different levels of  glycosylation result from differ- 
ences in the primary structure of the molecule, we amplified 
the coding region of 5E6 from different strains of mice. Com- 
parison of the amino acid sequence of 5E6 (Fig. 3) revealed 
that there is no change in the number of potential N-linked 
glycosylation sites. Other factor(s) might therefore contribute 
to the different level of glycosylation of the molecule. The 
implications  of  these varying sizes of  5E6 will be discussed later. 
Discussion 
In the present study, we describe the molecular character- 
ization of the gene encoding 5E6. The 5E6 molecule is ex- 
pressed on the surface of murine NK cells as a disulfide-linked 
homodimer. Spleen cells of most mouse strains express 5E6 
on "~40-50% of their NK cells, with the exception of 129/J, 
C57BR, and Rill mice. We have previously established that 
depletion of the 5E6 § subset of NK cells in vivo abrogates 
the ability of recipient mice to reject bone marrow cell grafts 
of H-2  a and H-2  f origin. These studies suggested that the 
5E6 §  subset of NK cells,  perhaps the 5E6 molecule itself, 
may be a receptor for Hh-1  determinant 2 (26, 27). We have 
now cloned the 5E6 cDNA using the mammalian expression- 
immunoselection procedure described by Seed and Aruffo (33) 
using a cDNA library made from IL-2-propagated NK cells 
from C.B-17 scid/scid bone marrow. The 5E6 gene was mapped 
to mouse chromosome 6 by two independent methods.  It 
was  also  found to be genetically linked to NKI.1  and Ly- 
49,4,  which are present in that portion of mouse chromo- 
some 6  termed the NK gene complex (23). 
A single transcript for the 5E6 gene 1.3 kb in length was 
present in total RNA isolated from A-LAK cells from the 
strains C57BL/6, BALB/c, DBA/2, C3H, and NZB but not 
from 129/J and Rill strains (data not shown). No detectable 
transcript was found in  RNA  from several normal tissues 
isolated from BALB/c mice. The mAb  SW5E6 was made 
by immunizing  129/J  mice with  purified  NK  cells  from 
C57BL/6 mice, therefore, it was expected that 129/J would 
not express 5E6. The significance of the lack of expression 
310  Cloning  of 5E6(Ly-49C),  a Natural Killer Cell-associated Receptor Molecule Figure  7.  Immunoprecipitation  of the 5E6 antigen synthesized  by 
C57BL/6, BALB/c,  BALB.B,  and (BALB/c x C57BL/6)F1  A-LAK  cells. 
Cell surface  proteins were labeled  with 125I, immunoprecipitated,  and dec- 
trophoresed in 12% SDS-PAGE under reducing conditions. (Lanes I-3) 
Immunoprecipitates  from C57BL/6  A-LAK  cell lysates. (Lanes  4-6) Im- 
munoprecipitates from BALB/c A-LAK cell lysates. (Lanes 7-9) Im- 
munoprecipitates from BALB.B  A-LAK  cell lysates. (Lanes I0-12) Im- 
munoprecipitates  from  CB6FI A-LAK  cell  lysates.  Immunopredpitates  in 
lanes 3, 6, 9, and 12 were digested  with endoglycosidase  F as indicated. 
The antibodies  used for each  immunoprecipitation  are indicated  below  each 
lane and are as follows:  control, isotype-matched,  irrelevant mAb 22B5; 
SW5E6,  mAb anti-SE6. The positions of the protein molecular mass 
markers (in kilodaltons) are indicated at the left. 
in the strain Rill is not known at this time. It is interesting 
that while 5E6 + cells apparently recognize and reject H-2a/ 
Hh-1 a bone marrow cell grafts, they are not deleted during 
development in H-2  a homozygous mice as evidenced by the 
presence of message in BALB/c and DBA/2 NK cells. It is 
also interesting to note that injection of SW5E6 antibodies 
had a minimal effect on the ability of H-2a/Hh-la-type  mice 
to clear radiolabeled YAC-1 tumor cells, but had a much more 
pronounced effect on animals with other H-2/Hh-1 types (26). 
It appears  as if the cytolytic function of 5E6 + cells against 
YAC-1  targets is somehow downregulated in H-2d/Hh-1 a 
mice.  It is possible  that the 5E6 §  subset of NK cells may 
have multiple functions in different strains of mice, This point 
will be mentioned later. 
The molecular weight of the 5E6 protein varied significantly 
depending on the strain of mice from which the NK cells 
were derived. Thus far, our analysis has revealed three different 
sizes of the 5E6 protein:  54 kD, present on C57BL/6 and 
CB6F1 mice; 60 kD, present on BALB.B mice; and 65 kD, 
present on BALB/c mice. When N-linked carbohydrates were 
removed, each of these had an identical molecular mass of 
31 kD, indicating that the difference in size between the strains 
is attributed to a varying amount of glycosylation. One pos- 
sibility is that the differences in the size of glycosylated mol- 
ecule could be caused by the differences in the primary struc- 
ture of the molecule in different strains of mice. However, 
as shown in Fig. 3, there is no difference in the number of 
potential N-linked glycosylation sites. Thus, other factor(s) 
might contribute to the level of glycosylation of the mole- 
cule in different strains of mice. Comparison of 5E6 from 
CB6F1 showed that it is identical to the B6 allele (Fig.  3). 
To determine whether F1 mice express  any BALB/c allele, 
we amplified by reverse transcription PCK a 184-bp  5' re- 
gion that contains two restriction sites (BgllI and MboI) in 
the BALB/c allele, but are absent in the B6 allele. Ethidium 
bromide staining of the PCK products and their digests with 
BgllI and MboI showed similar pattern for B6 and CB6F1 
(data not shown). Thus it appears that the CB6F1 NK cells 
contain only the B6 form of 5E6 mKNA. However, we cannot 
absolutely rule out that minute quantities of the BALB/c form 
of 5E6 mRNA are not present in CB6F1 NK cells because 
very low quantities of DNA cannot be visualized by ethidium 
bromide staining. It is noteworthy that both CB6F1  and 
C57BL/6 mice are able to reject BALB/c (H-2a/Hh-1 a) bone 
marrow cell grafts. The expression of only the C57BL/6 form 
of 5E6 in the CB6F1 could help explain some aspects of hy- 
brid resistance,  The differences seen in the sizes of BALB/c, 
BALB.B, and C57BL/6 5E6 molecules (65, 60, and 54 kD, 
respectively)  indicates that a factor associated with the H-2 
complex is important, but there are obviously other factors 
not associated with the H-2 complex that allow for a vari- 
ance in the glycosylation of 5E6.  It is entirely possible  that 
the degree of glycosylation present on the 5E6 protein is a 
determining factor in the recognition of alloantigens on bone 
marrow stem cells. It remains to be seen what exact  effect 
the difference in glycosylation  of the 5E6 protein has on NK 
cell function. 
The Ly-49A molecule is the only other well-characterized 
member of this multigene family. It is unknown ifLy-49 ex- 
hibits a similar pattern of glycosylation in different mice strains. 
Ly-49A § cells have been shown to receive a negative signal 
when  H-21M  class  I  molecules  are  encountered,  thus 
preventing the lysis of these targets (24,  51). Similar results 
have been obtained using an in vitro assay for hybrid resis- 
tance (Yu, Y. Y. L., J. Roland, V. Kumar, and M. Bennett, 
unpublished data). These data suggest that the 5E6 molecule 
on CB6F1 NK cells may receive negative signals from H-2  b 
(probably H-2K  b) but not H-2  a targets. It was noted that 
CB6F1 5E6 + NK cells could not lyse C57BL/6 (H-2  b) or 
B10.D2(K107)  (H-2KblbS~/DaL~  T  cell Con A blasts unless 
the effector cells were pretreated  with P(ab')2 anti-5E6 mAb. 
This data argues that negative signals received from MHC 
class I molecules, rather than positive signals received from 
putative Hh-1  determinants, mediate the presence or absence 
of "hybrid resistance" at least  in experiments using the in 
vitro system. However, Yu et al. also observed that BALB/c 
(H-2  a) Con A blasts, which are resistant to lysis by 5E6 + 
syngeneic NK cells, become susceptible to lysis when anti-5E6 
mAb is present, as if the 5E6 molecule can also recognize 
and receive negative signals from H-2  a. The currently avail- 
able data do not entirely exclude the possibility that 5E6 may 
also serve to activate NK cells in some cases. 5E6(Ly-49C)- 
311  Stoneman  et al. transfected cells were recently shown to bind to various class 
I molecules (52). It is conceivable that the 5E6 molecule may 
function as an activating molecule when H-2  a targets are en- 
countered by H-2  b or H-2  bxa NK cells, but as a negative sig- 
nalling receptor with respect to H-2  b targets. This provides 
an attractive explanation for the differences seen in the glyco- 
sylation of 5E6  in H-2  a homozygous versus other strains 
of mice. 
It is also noteworthy that NK cells of NZB (H-2  a) origin 
express the smaller (54 kD subunit) form of 5E6, as opposed 
to BALB/c (H-2a), which expresses  5E6 with 65-kD sub- 
units (data not shown). This is particularly interesting in view 
of the fact that treatment of recipient C57BL/6 mice with 
anti-5E6 mAb had no effect on their ability to reject NZB 
bone marrow cells (53). Therefore, we cannot be absolutely 
certain that NZB bone marrow cells express Hh-1 determinant 
2. Indeed, one study maps the gene for hybrid resistance to 
NZB bone marrow cells 32 cM telomeric of H-2 instead of 
near H-2,  as with other Hh-I  determinants (54). 
Another recent report (Murphy, W. J., A. Kaziuddin, L. 
Mason, V. Kumar, M. Bennett, and D. L. Longo, manuscript 
submitted for publication) demonstrate that 5E6 + and 5E6- 
subsets of NK cells can function differently in the regulation 
of hematopoiesis in different strains of mice. They observed 
that in H-2  a mice, 5E6 § cells produce more GM-CSF than 
IFN-'r and stimulate hematopoiesis, while 5E6-  cells pro- 
duce more INF-y than GM-CSF and inhibit hematopoiesis. 
In contrast the reverse is true in H-2  b mice: 5E6 + cells make 
more INF-3' than GM-CSF and inhibit hematopoiesis, while 
5E6-  cells make more GM-CSF than INF-  7  and stimulate 
hematopoiesis. These differences in cytokine secretion pat- 
terns in 5E6 + cells of H-2  b and H-2  a strains  of mice may 
also be related in some manner to the variation we report 
in the glycosylation of 5E6, 
Note added in proof Further PCR analysis has detected low levels 
of the BALB/c form of 5E6 mRNA in CB6F1 NK cells. 
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